Global Autoimmune Therapeutics Drugs Supply, Demand and Key Producers, 2023-2029

Description

The global Autoimmune Therapeutics Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Autoimmune Therapeutics Drugs demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Autoimmune Therapeutics Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Autoimmune Therapeutics Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Autoimmune Therapeutics Drugs total market, 2018-2029, (USD Million)
Global Autoimmune Therapeutics Drugs total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Autoimmune Therapeutics Drugs total market, key domestic companies and share, (USD Million)
Global Autoimmune Therapeutics Drugs revenue by player and market share 2018-2023, (USD Million)
Global Autoimmune Therapeutics Drugs total market by Type, CAGR, 2018-2029, (USD Million)
Global Autoimmune Therapeutics Drugs total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Autoimmune Therapeutics Drugs market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Amgen, Novartis, Eli Lilly and Company, Pfizer, Roche Holding AG, AstraZeneca, Abbott Laboratories and Genentech, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Autoimmune Therapeutics Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Autoimmune Therapeutics Drugs Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Autoimmune Therapeutics Drugs Market, Segmentation by Type
    NSAIDs
    Corticosteroids
    Disease-Modifying Anti-Rheumatic Drugs
    Monoclonal Antibodies

Global Autoimmune Therapeutics Drugs Market, Segmentation by Application
    Hospitals and Clinics
    Retail Pharmacies
    Online Pharmacies

Companies Profiled:
    AbbVie
    Amgen
    Novartis
    Eli Lilly and Company
    Pfizer
    Roche Holding AG
    AstraZeneca
    Abbott Laboratories
    Genentech
    Merck & Co.
    Bayer
    Biogen
    GlaxoSmithKline
    Perrigo

Key Questions Answered
1. How big is the global Autoimmune Therapeutics Drugs market?
2. What is the demand of the global Autoimmune Therapeutics Drugs market?
3. What is the year over year growth of the global Autoimmune Therapeutics Drugs market?
4. What is the total value of the global Autoimmune Therapeutics Drugs market?
5. Who are the major players in the global Autoimmune Therapeutics Drugs market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Autoimmune Therapeutics Drugs Introduction
    1.2 World Autoimmune Therapeutics Drugs Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Autoimmune Therapeutics Drugs Total Market by Region (by Headquarter Location)
        1.3.1 World Autoimmune Therapeutics Drugs Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Autoimmune Therapeutics Drugs Market Size (2018-2029)
        1.3.3 China Autoimmune Therapeutics Drugs Market Size (2018-2029)
        1.3.4 Europe Autoimmune Therapeutics Drugs Market Size (2018-2029)
        1.3.5 Japan Autoimmune Therapeutics Drugs Market Size (2018-2029)
        1.3.6 South Korea Autoimmune Therapeutics Drugs Market Size (2018-2029)
        1.3.7 ASEAN Autoimmune Therapeutics Drugs Market Size (2018-2029)
        1.3.8 India Autoimmune Therapeutics Drugs Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Autoimmune Therapeutics Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Autoimmune Therapeutics Drugs Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Autoimmune Therapeutics Drugs Consumption Value (2018-2029)
    2.2 World Autoimmune Therapeutics Drugs Consumption Value by Region
        2.2.1 World Autoimmune Therapeutics Drugs Consumption Value by Region (2018-2023)
        2.2.2 World Autoimmune Therapeutics Drugs Consumption Value Forecast by Region (2024-2029)
    2.3 United States Autoimmune Therapeutics Drugs Consumption Value (2018-2029)
    2.4 China Autoimmune Therapeutics Drugs Consumption Value (2018-2029)
    2.5 Europe Autoimmune Therapeutics Drugs Consumption Value (2018-2029)
    2.6 Japan Autoimmune Therapeutics Drugs Consumption Value (2018-2029)
    2.7 South Korea Autoimmune Therapeutics Drugs Consumption Value (2018-2029)
    2.8 ASEAN Autoimmune Therapeutics Drugs Consumption Value (2018-2029)
    2.9 India Autoimmune Therapeutics Drugs Consumption Value (2018-2029)

3 World Autoimmune Therapeutics Drugs Companies Competitive Analysis
    3.1 World Autoimmune Therapeutics Drugs Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Autoimmune Therapeutics Drugs Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Autoimmune Therapeutics Drugs in 2022
        3.2.3 Global Concentration Ratios (CR8) for Autoimmune Therapeutics Drugs in 2022
    3.3 Autoimmune Therapeutics Drugs Company Evaluation Quadrant
    3.4 Autoimmune Therapeutics Drugs Market: Overall Company Footprint Analysis
        3.4.1 Autoimmune Therapeutics Drugs Market: Region Footprint
        3.4.2 Autoimmune Therapeutics Drugs Market: Company Product Type Footprint
        3.4.3 Autoimmune Therapeutics Drugs Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Autoimmune Therapeutics Drugs Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Autoimmune Therapeutics Drugs Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Autoimmune Therapeutics Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Autoimmune Therapeutics Drugs Consumption Value Comparison
        4.2.1 United States VS China: Autoimmune Therapeutics Drugs Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Autoimmune Therapeutics Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Autoimmune Therapeutics Drugs Companies and Market Share, 2018-2023
        4.3.1 United States Based Autoimmune Therapeutics Drugs Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Autoimmune Therapeutics Drugs Revenue, (2018-2023)
    4.4 China Based Companies Autoimmune Therapeutics Drugs Revenue and Market Share, 2018-2023
        4.4.1 China Based Autoimmune Therapeutics Drugs Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Autoimmune Therapeutics Drugs Revenue, (2018-2023)
    4.5 Rest of World Based Autoimmune Therapeutics Drugs Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Autoimmune Therapeutics Drugs Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Autoimmune Therapeutics Drugs Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Autoimmune Therapeutics Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 NSAIDs
        5.2.2 Corticosteroids
        5.2.3 Disease-Modifying Anti-Rheumatic Drugs
        5.2.4 Monoclonal Antibodies
    5.3 Market Segment by Type
        5.3.1 World Autoimmune Therapeutics Drugs Market Size by Type (2018-2023)
        5.3.2 World Autoimmune Therapeutics Drugs Market Size by Type (2024-2029)
        5.3.3 World Autoimmune Therapeutics Drugs Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Autoimmune Therapeutics Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospitals and Clinics
        6.2.2 Retail Pharmacies
        6.2.3 Online Pharmacies
    6.3 Market Segment by Application
        6.3.1 World Autoimmune Therapeutics Drugs Market Size by Application (2018-2023)
        6.3.2 World Autoimmune Therapeutics Drugs Market Size by Application (2024-2029)
        6.3.3 World Autoimmune Therapeutics Drugs Market Size by Application (2018-2029)

7 Company Profiles
    7.1 AbbVie
        7.1.1 AbbVie Details
        7.1.2 AbbVie Major Business
        7.1.3 AbbVie Autoimmune Therapeutics Drugs Product and Services
        7.1.4 AbbVie Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 AbbVie Recent Developments/Updates
        7.1.6 AbbVie Competitive Strengths & Weaknesses
    7.2 Amgen
        7.2.1 Amgen Details
        7.2.2 Amgen Major Business
        7.2.3 Amgen Autoimmune Therapeutics Drugs Product and Services
        7.2.4 Amgen Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Amgen Recent Developments/Updates
        7.2.6 Amgen Competitive Strengths & Weaknesses
    7.3 Novartis
        7.3.1 Novartis Details
        7.3.2 Novartis Major Business
        7.3.3 Novartis Autoimmune Therapeutics Drugs Product and Services
        7.3.4 Novartis Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Novartis Recent Developments/Updates
        7.3.6 Novartis Competitive Strengths & Weaknesses
    7.4 Eli Lilly and Company
        7.4.1 Eli Lilly and Company Details
        7.4.2 Eli Lilly and Company Major Business
        7.4.3 Eli Lilly and Company Autoimmune Therapeutics Drugs Product and Services
        7.4.4 Eli Lilly and Company Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Eli Lilly and Company Recent Developments/Updates
        7.4.6 Eli Lilly and Company Competitive Strengths & Weaknesses
    7.5 Pfizer
        7.5.1 Pfizer Details
        7.5.2 Pfizer Major Business
        7.5.3 Pfizer Autoimmune Therapeutics Drugs Product and Services
        7.5.4 Pfizer Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Pfizer Recent Developments/Updates
        7.5.6 Pfizer Competitive Strengths & Weaknesses
    7.6 Roche Holding AG
        7.6.1 Roche Holding AG Details
        7.6.2 Roche Holding AG Major Business
        7.6.3 Roche Holding AG Autoimmune Therapeutics Drugs Product and Services
        7.6.4 Roche Holding AG Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Roche Holding AG Recent Developments/Updates
        7.6.6 Roche Holding AG Competitive Strengths & Weaknesses
    7.7 AstraZeneca
        7.7.1 AstraZeneca Details
        7.7.2 AstraZeneca Major Business
        7.7.3 AstraZeneca Autoimmune Therapeutics Drugs Product and Services
        7.7.4 AstraZeneca Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 AstraZeneca Recent Developments/Updates
        7.7.6 AstraZeneca Competitive Strengths & Weaknesses
    7.8 Abbott Laboratories
        7.8.1 Abbott Laboratories Details
        7.8.2 Abbott Laboratories Major Business
        7.8.3 Abbott Laboratories Autoimmune Therapeutics Drugs Product and Services
        7.8.4 Abbott Laboratories Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Abbott Laboratories Recent Developments/Updates
        7.8.6 Abbott Laboratories Competitive Strengths & Weaknesses
    7.9 Genentech
        7.9.1 Genentech Details
        7.9.2 Genentech Major Business
        7.9.3 Genentech Autoimmune Therapeutics Drugs Product and Services
        7.9.4 Genentech Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Genentech Recent Developments/Updates
        7.9.6 Genentech Competitive Strengths & Weaknesses
    7.10 Merck & Co.
        7.10.1 Merck & Co. Details
        7.10.2 Merck & Co. Major Business
        7.10.3 Merck & Co. Autoimmune Therapeutics Drugs Product and Services
        7.10.4 Merck & Co. Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Merck & Co. Recent Developments/Updates
        7.10.6 Merck & Co. Competitive Strengths & Weaknesses
    7.11 Bayer
        7.11.1 Bayer Details
        7.11.2 Bayer Major Business
        7.11.3 Bayer Autoimmune Therapeutics Drugs Product and Services
        7.11.4 Bayer Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Bayer Recent Developments/Updates
        7.11.6 Bayer Competitive Strengths & Weaknesses
    7.12 Biogen
        7.12.1 Biogen Details
        7.12.2 Biogen Major Business
        7.12.3 Biogen Autoimmune Therapeutics Drugs Product and Services
        7.12.4 Biogen Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Biogen Recent Developments/Updates
        7.12.6 Biogen Competitive Strengths & Weaknesses
    7.13 GlaxoSmithKline
        7.13.1 GlaxoSmithKline Details
        7.13.2 GlaxoSmithKline Major Business
        7.13.3 GlaxoSmithKline Autoimmune Therapeutics Drugs Product and Services
        7.13.4 GlaxoSmithKline Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 GlaxoSmithKline Recent Developments/Updates
        7.13.6 GlaxoSmithKline Competitive Strengths & Weaknesses
    7.14 Perrigo
        7.14.1 Perrigo Details
        7.14.2 Perrigo Major Business
        7.14.3 Perrigo Autoimmune Therapeutics Drugs Product and Services
        7.14.4 Perrigo Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Perrigo Recent Developments/Updates
        7.14.6 Perrigo Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Autoimmune Therapeutics Drugs Industry Chain
    8.2 Autoimmune Therapeutics Drugs Upstream Analysis
    8.3 Autoimmune Therapeutics Drugs Midstream Analysis
    8.4 Autoimmune Therapeutics Drugs Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Autoimmune Therapeutics Drugs Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Autoimmune Therapeutics Drugs Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Autoimmune Therapeutics Drugs Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Autoimmune Therapeutics Drugs Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Autoimmune Therapeutics Drugs Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Autoimmune Therapeutics Drugs Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Autoimmune Therapeutics Drugs Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Autoimmune Therapeutics Drugs Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Autoimmune Therapeutics Drugs Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Autoimmune Therapeutics Drugs Players in 2022
    Table 12. World Autoimmune Therapeutics Drugs Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Autoimmune Therapeutics Drugs Company Evaluation Quadrant
    Table 14. Head Office of Key Autoimmune Therapeutics Drugs Player
    Table 15. Autoimmune Therapeutics Drugs Market: Company Product Type Footprint
    Table 16. Autoimmune Therapeutics Drugs Market: Company Product Application Footprint
    Table 17. Autoimmune Therapeutics Drugs Mergers & Acquisitions Activity
    Table 18. United States VS China Autoimmune Therapeutics Drugs Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Autoimmune Therapeutics Drugs Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Autoimmune Therapeutics Drugs Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Autoimmune Therapeutics Drugs Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Autoimmune Therapeutics Drugs Revenue Market Share (2018-2023)
    Table 23. China Based Autoimmune Therapeutics Drugs Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Autoimmune Therapeutics Drugs Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Autoimmune Therapeutics Drugs Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Autoimmune Therapeutics Drugs Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Autoimmune Therapeutics Drugs Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Autoimmune Therapeutics Drugs Revenue Market Share (2018-2023)
    Table 29. World Autoimmune Therapeutics Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Autoimmune Therapeutics Drugs Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Autoimmune Therapeutics Drugs Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Autoimmune Therapeutics Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Autoimmune Therapeutics Drugs Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Autoimmune Therapeutics Drugs Market Size by Application (2024-2029) & (USD Million)
    Table 35. AbbVie Basic Information, Area Served and Competitors
    Table 36. AbbVie Major Business
    Table 37. AbbVie Autoimmune Therapeutics Drugs Product and Services
    Table 38. AbbVie Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. AbbVie Recent Developments/Updates
    Table 40. AbbVie Competitive Strengths & Weaknesses
    Table 41. Amgen Basic Information, Area Served and Competitors
    Table 42. Amgen Major Business
    Table 43. Amgen Autoimmune Therapeutics Drugs Product and Services
    Table 44. Amgen Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Amgen Recent Developments/Updates
    Table 46. Amgen Competitive Strengths & Weaknesses
    Table 47. Novartis Basic Information, Area Served and Competitors
    Table 48. Novartis Major Business
    Table 49. Novartis Autoimmune Therapeutics Drugs Product and Services
    Table 50. Novartis Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Novartis Recent Developments/Updates
    Table 52. Novartis Competitive Strengths & Weaknesses
    Table 53. Eli Lilly and Company Basic Information, Area Served and Competitors
    Table 54. Eli Lilly and Company Major Business
    Table 55. Eli Lilly and Company Autoimmune Therapeutics Drugs Product and Services
    Table 56. Eli Lilly and Company Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Eli Lilly and Company Recent Developments/Updates
    Table 58. Eli Lilly and Company Competitive Strengths & Weaknesses
    Table 59. Pfizer Basic Information, Area Served and Competitors
    Table 60. Pfizer Major Business
    Table 61. Pfizer Autoimmune Therapeutics Drugs Product and Services
    Table 62. Pfizer Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Pfizer Recent Developments/Updates
    Table 64. Pfizer Competitive Strengths & Weaknesses
    Table 65. Roche Holding AG Basic Information, Area Served and Competitors
    Table 66. Roche Holding AG Major Business
    Table 67. Roche Holding AG Autoimmune Therapeutics Drugs Product and Services
    Table 68. Roche Holding AG Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Roche Holding AG Recent Developments/Updates
    Table 70. Roche Holding AG Competitive Strengths & Weaknesses
    Table 71. AstraZeneca Basic Information, Area Served and Competitors
    Table 72. AstraZeneca Major Business
    Table 73. AstraZeneca Autoimmune Therapeutics Drugs Product and Services
    Table 74. AstraZeneca Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. AstraZeneca Recent Developments/Updates
    Table 76. AstraZeneca Competitive Strengths & Weaknesses
    Table 77. Abbott Laboratories Basic Information, Area Served and Competitors
    Table 78. Abbott Laboratories Major Business
    Table 79. Abbott Laboratories Autoimmune Therapeutics Drugs Product and Services
    Table 80. Abbott Laboratories Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Abbott Laboratories Recent Developments/Updates
    Table 82. Abbott Laboratories Competitive Strengths & Weaknesses
    Table 83. Genentech Basic Information, Area Served and Competitors
    Table 84. Genentech Major Business
    Table 85. Genentech Autoimmune Therapeutics Drugs Product and Services
    Table 86. Genentech Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Genentech Recent Developments/Updates
    Table 88. Genentech Competitive Strengths & Weaknesses
    Table 89. Merck & Co. Basic Information, Area Served and Competitors
    Table 90. Merck & Co. Major Business
    Table 91. Merck & Co. Autoimmune Therapeutics Drugs Product and Services
    Table 92. Merck & Co. Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Merck & Co. Recent Developments/Updates
    Table 94. Merck & Co. Competitive Strengths & Weaknesses
    Table 95. Bayer Basic Information, Area Served and Competitors
    Table 96. Bayer Major Business
    Table 97. Bayer Autoimmune Therapeutics Drugs Product and Services
    Table 98. Bayer Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Bayer Recent Developments/Updates
    Table 100. Bayer Competitive Strengths & Weaknesses
    Table 101. Biogen Basic Information, Area Served and Competitors
    Table 102. Biogen Major Business
    Table 103. Biogen Autoimmune Therapeutics Drugs Product and Services
    Table 104. Biogen Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Biogen Recent Developments/Updates
    Table 106. Biogen Competitive Strengths & Weaknesses
    Table 107. GlaxoSmithKline Basic Information, Area Served and Competitors
    Table 108. GlaxoSmithKline Major Business
    Table 109. GlaxoSmithKline Autoimmune Therapeutics Drugs Product and Services
    Table 110. GlaxoSmithKline Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. GlaxoSmithKline Recent Developments/Updates
    Table 112. Perrigo Basic Information, Area Served and Competitors
    Table 113. Perrigo Major Business
    Table 114. Perrigo Autoimmune Therapeutics Drugs Product and Services
    Table 115. Perrigo Autoimmune Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 116. Global Key Players of Autoimmune Therapeutics Drugs Upstream (Raw Materials)
    Table 117. Autoimmune Therapeutics Drugs Typical Customers
List of Figure
    Figure 1. Autoimmune Therapeutics Drugs Picture
    Figure 2. World Autoimmune Therapeutics Drugs Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Autoimmune Therapeutics Drugs Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Autoimmune Therapeutics Drugs Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Autoimmune Therapeutics Drugs Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Autoimmune Therapeutics Drugs Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Autoimmune Therapeutics Drugs Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Autoimmune Therapeutics Drugs Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Autoimmune Therapeutics Drugs Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Autoimmune Therapeutics Drugs Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Autoimmune Therapeutics Drugs Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Autoimmune Therapeutics Drugs Revenue (2018-2029) & (USD Million)
    Figure 13. Autoimmune Therapeutics Drugs Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Autoimmune Therapeutics Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Autoimmune Therapeutics Drugs Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Autoimmune Therapeutics Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Autoimmune Therapeutics Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Autoimmune Therapeutics Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Autoimmune Therapeutics Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Autoimmune Therapeutics Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Autoimmune Therapeutics Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Autoimmune Therapeutics Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Autoimmune Therapeutics Drugs by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Autoimmune Therapeutics Drugs Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Autoimmune Therapeutics Drugs Markets in 2022
    Figure 27. United States VS China: Autoimmune Therapeutics Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Autoimmune Therapeutics Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Autoimmune Therapeutics Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Autoimmune Therapeutics Drugs Market Size Market Share by Type in 2022
    Figure 31. NSAIDs
    Figure 32. Corticosteroids
    Figure 33. Disease-Modifying Anti-Rheumatic Drugs
    Figure 34. Monoclonal Antibodies
    Figure 35. World Autoimmune Therapeutics Drugs Market Size Market Share by Type (2018-2029)
    Figure 36. World Autoimmune Therapeutics Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 37. World Autoimmune Therapeutics Drugs Market Size Market Share by Application in 2022
    Figure 38. Hospitals and Clinics
    Figure 39. Retail Pharmacies
    Figure 40. Online Pharmacies
    Figure 41. Autoimmune Therapeutics Drugs Industrial Chain
    Figure 42. Methodology
    Figure 43. Research Process and Data Source